Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • TheStudent
    Member
    • Nov 2011
    • 10

    #1

    Enough reads in Chip-Seq?

    Dear Community,

    I am new to ChIP-seq so please be gentle.

    Analyzing ChIP-seq data - public and from my collaborators - I realized that the minimum of reads is varying very much - NCBI's minimum to submit ChIP-seq is 1 million short reads I heard and I saw published data with even less than that.

    Looking at the distribution of reads in UCSC browser (by uploading the .bam files) it looks very random over the whole genome, sometimes reads are stacking up a bit.

    Here the questions:

    A) Should you normally be able to spot peaks visually?
    The peak callers take into account fragment size as well I suppose, but usually should you be able to see distinct peaks by eye?

    B) If not - if it looks all over the genome, does that mean that there are not enough reads to detect peaks reliable?

    C) How many reads would you recommend minimum for Illumina GAIIx - read length 37 - 42nt for TFs like Myc-n or NFkB-p50?

    Thank you very much
  • ffinkernagel
    Senior Member
    • Oct 2009
    • 110

    #2
    A) Very much so.
    B) Either that or your ChIP did not work.
    C) Very much depends on the antibody, and the portion of the genome covered by your factor. For those two, I'd start at minimum of 20 million reads, but I'd expect a need to increase the depth.

    Comment

    • TheStudent
      Member
      • Nov 2011
      • 10

      #3
      thanks,

      It is expected that those factors bind a lot in the genome

      Comment

      • ffinkernagel
        Senior Member
        • Oct 2009
        • 110

        #4
        Indeed - but then at least for myc I know that the antibody is pretty decent.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...